that's because nothing much is happening.. covid has likely impacted their consulting arm of the business, in particular the cc hygiene / environmental science risk management revenue which in turn I think you will see a decline lab / analytical services.
no innovation, just acquisition after acquisition. Dont think it will survive without continuing to acquire.. which is touch when cash is low to covid losses
just my thoughts..
